The bill modifies the existing drug take-back program in Washington by updating fee structures, enforcement regulations, and performance reporting requirements for program operators. Key changes include the requirement for program operators to submit detailed annual reports to the Department of Health, which must now include specific information about collection amounts, public education efforts, and financial expenditures. Additionally, the Department is granted the authority to evaluate these reports for compliance and to request revisions if discrepancies are found. The bill also introduces a one-time fee of $70,000 to be evenly split among approved program operators to fund an expedited review of the Department's fee-setting authority.

Furthermore, the bill enhances the enforcement mechanisms for noncompliance with the drug take-back program, allowing the Department to issue warnings and impose penalties on manufacturers and program operators that fail to meet their obligations. It establishes a new section for the Joint Legislative Audit and Review Committee to conduct an expedited review of the program's fee-setting authority, ensuring transparency and appropriateness of expenditures. The bill also includes provisions for the repeal of certain sections of the existing law effective January 1, 2030, as part of the overall restructuring of the drug take-back program.

Statutes affected:
Original Bill: 69.48.100, 69.48.110, 69.48.120, 69.48.130, 43.131.424
Substitute Bill: 69.48.100, 69.48.110, 69.48.120, 69.48.130
Second Substitute: 69.48.100, 69.48.110, 69.48.120, 69.48.130
Engrossed Second Substitute: 69.48.100, 69.48.110, 69.48.120, 43.131.424
Bill as Passed Legislature: 69.48.100, 69.48.110, 69.48.120, 43.131.424
Session Law: 69.48.100, 69.48.110, 69.48.120, 43.131.424